Judith Shizuru's most recent trade in Jasper Therapeutics Inc was a trade of 41,000 Common Stock Warrant (right to buy) done . Disclosure was reported to the exchange on Sept. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jasper Therapeutics Inc | Judith Shizuru | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Sep 2025 | 41,000 | 41,000 | - | - | Common Stock Warrant (right to buy) | |
| Jasper Therapeutics Inc | Judith Shizuru | Director | Purchase of securities on an exchange or from another person at price $ 2.43 per share. | 22 Sep 2025 | 41,000 | 156,901 | - | 2.4 | 99,630 | Voting Common Stock |
| Jasper Therapeutics Inc | Judith Shizuru | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Judith Shizuru | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Judith Shizuru | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 47,000 | 47,000 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Judith Shizuru | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2022 | 29,500 | 1,159,012 | - | 0 | Voting Common Stock | |
| Jasper Therapeutics Inc | Judith Shizuru | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 78,045 | 78,045 | - | - | Stock Option (right to buy) |